Science, medicine, and the future: Alzheimer's disease

BMJ

Volumn 316, Issue 7129, 1998, Pages 446-

  Masters, Colin L ^a   Beyreuther, Konrad ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DONEPEZIL; TACRINE;

AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; ENVIRONMENTAL FACTOR; GENE MUTATION; GENE THERAPY; GENETIC RISK; HUMAN; MOLECULAR BIOLOGY; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; FORECASTING; GENETICS; REVIEW;

ALZHEIMER DISEASE; FORECASTING; HUMANS; RISK FACTORS;

EID: 85007768150     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7129.446     Document Type: Article

References (7)

1. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154–9.
2. Selkoe D.J. Amyloid ß-protein and the genetics of Alzheimer's disease. J Biol Chem 1996;271:18295–8.
3. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996;16:921–32.
4. Kim T.-W. Tanzi R.E. Presenilins and Alzheimer's disease. Curr Opin Neurobiol 1997;7:683–8.
5. Struchler-Pierrat C. Abramowski D. Duke M. Wiederhold K.-H. Mistl C. Rothacher S et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997;94:13287–92.
6. Wimo A. Karlsson G. Nordberg A. Winblad B. Treatment of Alzheimer disease with tacrine: a cost-analysis model. Alzheimer Dis Assoc Disord 1997;11:191–200.
7. Cavallo M.C. Fattore G. The economic burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Dis Assoc Disord 1997;11:184–90